# Structural and Functional Analyses of Trypanosoma brucei Nucleoside Diphosphate Kinase

## TL;DR

This study explores the structure and function of a key enzyme in the parasite causing African trypanosomiasis, highlighting its potential as a drug target.

## Contribution

The paper provides new structural and functional insights into TbNDPK, revealing its stability and substrate specificity.

## Key findings

- TbNDPK is highly stable under thermal and chemical stress and undergoes conformational changes with nucleotides.
- Crystal structures show a conserved hexameric fold with induced-fit binding involving Phe59 and active-site residues.
- Enzymatic assays show preference for UDP and GDP, with reduced efficiency for deoxyribonucleotide diphosphates.

## Abstract

Trypanosoma
brucei, the causative
agent of Human African Trypanosomiasis (HAT), relies exclusively on
purine salvage for nucleotide biosynthesis, making its nucleotide-processing
enzymes attractive drug targets. Here, we present a comprehensive
structural and functional characterization of T. brucei’s nucleoside diphosphate kinase B (TbNDPK),
a key enzyme in nucleotide homeostasis. Circular dichroism and fluorescence
spectroscopy revealed that TbNDPK is highly stable
under thermal and chemical stress and undergoes nucleotide-induced
conformational changes. This study also presents high-resolution crystal
structures of the apo enzyme and complexes with UDP,
CDP, and GDP, showing a conserved hexameric fold, with induced-fit
binding via a flexible loop involving Phe59 and key active-site residues.
Enzymatic assays revealed substrate preferences for UDP and GDP, while
deoxyribonucleotide diphosphates were processed with significantly
reduced efficiency. Molecular dynamics simulations revealed ligand-dependent
flexibility and subunit-specific nucleotide dynamics, indicating potential
asymmetry and cooperative communication within the hexamer. Collectively,
these findings position TbNDPK as a thermostable,
catalytically efficient, and structurally distinct enzyme optimized
for ribonucleotide metabolism and support its potential as a selective
target for future antitrypanosomal drug discovery.